Loading…
Based on limited metadata, the FDA issued a warning letter to Mr. Pink Collections, LLC on November 22, 2019, regarding drug products. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be detailed; however, the warning indicates the company's drug products did not meet FDA requirements or standards. This enforcement action falls under the FDA's drug regulation authority, though the specific issuing office is not identified in the available metadata.